What if you'd held MRNA?
A $1,000 investment in Moderna, Inc. (MRNA) at the month-end close of 2018-12 would be worth $11,420 at the close of 2026-08 — +1042.0% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,075.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2018
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2018 | $1,000 | — |
| 2019 | $1,281 | +28.1% |
| 2020 | $6,842 | +434.1% |
| 2021 | $16,633 | +143.1% |
| 2022 | $11,763 | -29.3% |
| 2023 | $6,513 | -44.6% |
| 2024 | $2,723 | -58.2% |
| 2025 | $1,931 | -29.1% |
| 2026 | $11,420 | +491.3% |
Best and worst month-end to buy
The best single month-end close to have bought MRNA was 2019-07 ($13.10): $1,000 then is $13,311 today. The worst was 2021-09 ($385): $1,000 then is $453.
FAQ
What would $1,000 in MRNA be worth today?
A $1,000 investment in Moderna, Inc. (MRNA) at the start of 2018 would be worth about $11,420 today, a total return of +1042.0%. Dividends are reinvested in these figures.
What were the best and worst years for MRNA?
Moderna, Inc. (MRNA)'s strongest calendar year since 2018 was 2026, a +491.3% return — $1,000 held through that year became about $5,913 by year-end. Its weakest year was 2024, at -58.2%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in MRNA have grown?
Investing $100 at the end of every month since 2018-12 would have grown to about $33,959 on $9,300 invested.
Did MRNA beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,075. MRNA beat the S&P 500 by +271.4% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Moderna, Inc. (MRNA) historical total-return data from 2018-12 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.